Last update:
Medications news
Medications
Semaglutide can also be beneficial to people with type 1 diabetes, clinical trial finds
Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially approved for managing type 2 diabetes. While there is currently limited data on its risks and benefits ...
31 minutes ago
0
0
Medications
Study shows IVF pregnancies are at greater risk of exposure to medicines that can harm the fetus
A new Australian study has revealed a potential reason why some pregnancies achieved through assisted reproductive technology (ART) may result in birth defects in comparison to naturally conceived pregnancies. The study has ...
5 hours ago
0
0
Diabetes drug metformin linked to reduced skin cancer risk
A popular diabetes drug may provide protection against skin cancers, a new study says.
18 hours ago
0
2
Why some osteoporosis drugs may protect against COVID-19
Researchers have provided the molecular explanation for why some osteoporosis drugs offer protection against COVID-19.
Jan 14, 2025
0
0
Commonly prescribed medications can increase fall risk and related injuries in people with COPD
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a recent study. The research is published in Chronic Obstructive Pulmonary Diseases: ...
Jan 14, 2025
0
0
Researchers investigate reports of painful skin when tapering cortisone cream
Painful skin and trouble sleeping are among the problems reported when tapering cortisone cream for atopic eczema. This has been shown by a study headed by the University of Gothenburg. Many users consider the problems to ...
Jan 14, 2025
0
0
What to do if you miss a dose of GLP-1
Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug—better known as GLP-1—for weight loss, the protocol for getting back on track may be different ...
Jan 13, 2025
0
0
Q&A: Why are antidepressants underprescribed?
The University of Virginia's Dr. Anita Clayton has been a primary investigator for nearly every antidepressant approved in the United States since 1990.
Jan 13, 2025
0
0
With more Americans able to access legalized marijuana, fewer are picking up prescriptions for anti-anxiety medications
In states where both medical and recreational marijuana are legal, fewer patients are filling prescriptions for medications used to treat anxiety. That is the key finding of my recent study, published in the journal JAMA ...
Jan 13, 2025
0
0
Study finds no elevated risk of thyroid cancer among GLP1-RA users
A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer.
Jan 13, 2025
0
0
Clinical trial highlights promising new treatment for intestinal worms
A new tablet combining albendazole and ivermectin is safe and more effective than albendazole alone in treating Trichuris trichiura and other soil-transmitted helminths (STH), according to a clinical trial conducted by the ...
Jan 10, 2025
0
18
Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs
A new study examining the use of high-cost drugs among patients with colorectal cancer and non-small cell lung cancer found those insured through Medicare Advantage received less expensive cancer drugs compared to others ...
Jan 10, 2025
0
18
Medicare rules may reduce prescription steering
Weill Cornell Medicine researchers have found that pharmacy benefit managers (PBMs)—organizations that negotiate access to medicines for most patients in the United States—steer patients to use their own pharmacies. However, ...
Jan 10, 2025
0
0
Data-driven study reveals falling use of antiseizure drug in pregnancy
University of Liverpool researchers have contributed to the largest study to date on sodium valproate use. This significant report shows decreased use in women of childbearing age and during pregnancy, as well as young men, ...
Jan 10, 2025
0
0
New drug for prostate cancer patients in clinical trials
Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in the journal Clinical ...
Jan 10, 2025
0
1
Some maternal medications lower levels of protein, fat in breastmilk
Some maternal medications are associated with lower levels of protein and fat in breastmilk, according to a study published online Jan. 7 in JAMA Network Open.
Jan 10, 2025
0
0
Tuberculosis research: Scientists demonstrate effectiveness of a new antibiotic
A consortium including scientists from the Tropical Institute at LMU University Hospital has demonstrated the effectiveness of a new antibiotic. Tuberculosis is the most common infectious disease worldwide. In the year 2022 ...
Jan 9, 2025
0
3
PCT blood test does not lower antibiotic treatment duration for hospitalized children, study shows
A new U.K. study led by the University of Liverpool has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in hospitals.
Jan 9, 2025
0
0
Oral glucose-lowering agents are potential alternatives to insulin for gestational diabetes
With respect to the proportion of infants born large for gestational age, treatment of gestational diabetes with metformin and glyburide, if needed, does not meet the criteria for noninferiority versus insulin, according ...
Jan 9, 2025
0
0
Talquetamab plus teclistamab shows promise in multiple myeloma
For patients with relapsed or refractory multiple myeloma, talquetamab plus teclistamab shows response in a high percentage of patients and a higher incidence of grade 3 or 4 infections than with either therapy alone, according ...
Jan 9, 2025
0
1
Extended nirmatrelvir/ritonavir found to be beneficial for some with long COVID
Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist, according to a case series published online Jan. 6 in Communications Medicine.
Jan 9, 2025
0
0
Systematic review finds potential in glutamatergic medications for OCD treatment
A systematic review and meta-analysis from the Harvard T.H. Chan School of Public Health reported a large effect of glutamatergic medications on improving symptoms of obsessive-compulsive and related disorders (OCRDs). The ...
High-cost outliers distort public discussions about drug development costs, study says
The typical cost of developing new medications may not be as high as generally believed, with a few ultra-costly medications skewing public discussions about the cost of pharmaceutical research and development, according ...
Jan 7, 2025
0
5
Incident gabapentin use not linked to increase in falls vs. duloxetine
Incident use of gabapentin is not associated with an increase in fall-related hospital visits compared with duloxetine use, according to a study published online Jan. 7 in the Annals of Internal Medicine.
Jan 7, 2025
0
0
Approved drug dronedarone found to inhibit the proliferation of esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and contributing significantly to cancer-related mortality globally. Despite advancements in combination ...
Jan 7, 2025
0
0
